Photodynamic Therapy for Cancer: What's Past is Prologue

259Citations
Citations of this article
280Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Thomas J Dougherty from Roswell Park Cancer Center played a major role in the progress of photodynamic therapy (PDT) from a laboratory science into a real-world clinical therapy to treat patients with cancer. Nevertheless over the succeeding 45 years, it is fair to say that the overall progress of clinical PDT for cancer has been somewhat disappointing. The goal of this perspective article is to summarize some of the clinical trials run by various companies using photosensitizers with different structures that have been conducted for different types of cancer. While some have been successful, others have failed, and several are now ongoing. I will attempt to touch on some factors, which have influenced this checkered history and look forward to the future of clinical PDT for cancer.

Cite

CITATION STYLE

APA

Hamblin, M. R. (2020, May 1). Photodynamic Therapy for Cancer: What’s Past is Prologue. Photochemistry and Photobiology. Blackwell Publishing Inc. https://doi.org/10.1111/php.13190

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free